1) multi-drug resistant
耐多种药物性
2) multi-drug resistant
耐多药
1.
Fiberoptic bronchoscopic interventional therapy of multi-drug resistant caseous tuberculous pneumonia with gel containing drugs;
含药凝胶经纤维支气管镜介入治疗耐多药结核性干酪性肺炎
2.
Efficacy of freeze-dried M. vaccae vaccine in treatment of patients with multi-drug resistant pulmonary tuberculosis;
冻干治疗用母牛分支杆菌菌苗对耐多药肺结核患者临床疗效及细胞免疫功能的影响
3.
Experience in treating 86 patients with multi-drug resistant pulmonary tuberculosis by used ALP ( amikacin, levofloxacin, sodium, aminosalicylate ) regimen;
ALP方案治疗86例耐多药结核病的疗效分析
3) multiple drug-resistance
耐多药性
1.
Survey on multiple drug-resistance to mycrobacteria in Changzhi region;
长治地区结核分枝杆菌的耐多药性研究
4) Multidrug resistance
耐多药
1.
Multidrug resistance of Mycobacterium tuberculosis in different age groups;
耐多药结核病例不同年龄组耐药性分析
2.
Objective To search for the new proteins related to multidrug resistance,the proteomics of whole cellular proteins between sensitive strain and induced anti-multidrug strain of shigella flexneri by using of two-dimensional electrophoresis(2-DE) were compared.
目的对志贺菌敏感株与诱导耐多药株全菌蛋白进行蛋白质组学比较,寻找细菌耐多药相关蛋白。
3.
Objective To evaluate the therapeutic effects of bacillus calmette guerin (BCG) in the adjunctive treatment of multidrug resistance tuberculosis (MDR-TB).
目的评价卡提素辅助治疗耐多药结核病(MDR-TB)的疗效。
5) multidrug-resistant
耐多药
6) Multi-drug resistance
耐多药
1.
Objective In order to search for the new proteins realated to multi-drug resistance,the proteomics of whole cellular proteins between sensitive strain and gene transferred multi-drug resistance strain of shigella flexneri by using of two-dimensional electrophoresis(2-DE) were compared.
目的对志贺菌敏感株与基因转移耐多药株全菌蛋白进行蛋白质组比较,寻找细菌耐多药相关蛋白。
2.
The number of patients with multi-drug resistance were 250 (44.
9% ;其中耐多药的有 2 5 0例 ,占总患者的 4 4 。
3.
Methods: The tuberculosis of multi-drug resistance were treated with capreomycin, pasinizide, ofloxacin, rifampin compound and pyrazinamide for one year.
目的：探讨合静脉滴注卷曲霉素方案对耐多药肺结核患者的治疗效果。
参考词条
补充资料：放射性碘标记的放射性药物
分子式：
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。